Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-04
2006-07-04
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S555000
Reexamination Certificate
active
07071185
ABSTRACT:
Compounds of Formula I or a pharmaceutically acceptable salt thereof are provided:where R1through R7are defined herein. The compounds of Formula I are 5HT2cagonists or partial agonists, and are useful for treating a variety of disorders.
REFERENCES:
patent: 3158619 (1964-11-01), Wagner
patent: 3235564 (1966-02-01), Wagner
patent: 3296252 (1967-01-01), Frey
patent: 3329676 (1967-07-01), Bell
patent: 3335134 (1967-08-01), Frey
patent: 3417101 (1968-12-01), Bell
patent: 3466274 (1969-09-01), Ridder
patent: 3714149 (1973-01-01), Hester
patent: 3914250 (1975-10-01), Kim
patent: 4880814 (1989-11-01), Chu
patent: 4997831 (1991-03-01), Bays
patent: 5045545 (1991-09-01), Bays
patent: 5834454 (1998-11-01), Kitano et al.
patent: 6414144 (2002-07-01), Welmaker
patent: 6503900 (2003-01-01), Sabb et al.
patent: 2002/0055504 (2002-05-01), Chan
patent: 2002/0058689 (2002-05-01), Welmaker
patent: 2002/0062022 (2002-05-01), Sabb
patent: 2002/0107242 (2002-08-01), Sabb et al.
patent: 2002/0119966 (2002-08-01), Sabb et al.
patent: 2002/0128261 (2002-09-01), Sabb et al.
patent: 2002/0173503 (2002-11-01), Robichaud et al.
patent: 2003/0050300 (2003-03-01), McWhorter, Jr.
patent: 2004/0009970 (2004-01-01), Ramamoorthy et al.
patent: 2004/0034005 (2004-02-01), Gao et al.
patent: 0 344 015 (1989-11-01), None
patent: 0 357 417 (1990-03-01), None
patent: 02-040379 (1990-02-01), None
patent: 10-237073 (1998-09-01), None
patent: 2001-89461 (2001-04-01), None
patent: 930902 (1982-11-01), None
patent: WO 90/15058 (1990-12-01), None
patent: WO 96/29316 (1996-09-01), None
patent: WO 97/30999 (1997-08-01), None
patent: WO 97/31000 (1997-08-01), None
patent: WO 99/66934 (1999-12-01), None
patent: WO 99/67219 (1999-12-01), None
patent: WO 00/35922 (2000-06-01), None
patent: WO 00/40226 (2000-07-01), None
patent: WO 00/64899 (2000-11-01), None
patent: WO 00/77002 (2000-12-01), None
patent: WO 01/12602 (2001-02-01), None
patent: WO 01/12603 (2001-02-01), None
patent: WO 01/64246 (2001-09-01), None
patent: WO 02/08186 (2002-01-01), None
patent: WO 02/36596 (2002-05-01), None
patent: WO 02/42304 (2002-05-01), None
patent: WO 02/059124 (2002-08-01), None
patent: WO 02/059129 (2002-08-01), None
Gregory E. Martin et al., J. Med. Chem., 32, 1052-1056 (1989).
J.L. Browning et al., Society for Neuroscience Abstracts, 25(2), 2075, Abstract 830.12, (1999).
Jackson B. Hester et al., J. Med. Chem., 13,827-835 (1970).
Dong H. Kim, J. Heterocycl. Chem., 13(6), 1187-1192 (1976).
H.P. Haerter et al., Chimia, 30, 50-52 (1976).
Oliver H. Lowry et al., J. Biol. Chem., 193, 265-275 (1951).
Samuel H. Wilen, et al., Tetrahedron, 33, 2725-2736 (1977).
Shunji Naruto et al., Tetrahedron Letters, 39, 3399-3402 (1975).
Giuseppe Digiovanni et al., Synapse, 35, 53-61 (2000).
Vincenzo Dimatteo et al., Neuropharmacology, 37, 265-272 (1998).
Vincenzo Dimatteo, et al., Neuropharmacology, 38, 1195-1205 (1999).
M.J. Millan et al., Neuropharmacology, 37, 953-955 (1998).
Prakash S. Masand, Exp. Opin. Pharmacother, 1(3), 377-389 (2000).
David B. Allison et al., Am. J. Psychiatry, 156(11), 1686-1696 (1999).
P.J. Cowan et al., Human Psychopharmacology, 10, 385-391 (1995).
A. Schotte et al., Psychopharmacology, 124, 57-73 (1996).
Susan H. Fox et al., Experimental Neurology, 151, 35-49 (1998).
R. Whitaker, Spectrum, 2, 1-12 (2000).
A.N. Grinev et al., Chem. Heterocycl. Compd., 19(9), 959-961 (1983).
A.N. Grinev et al., Chem. Heterocycl. Compd., 19(12), 1312-1315 (1983).
E.V. Lamanova et al., Pharm. Chem., J., 23(2), 113-115 (1989).
D.H. Kim et al., Journal of Medicinal Chemistry, 20(2), 209-212 (1977).
L. Toscano et al., J. Heterocyclic Chem., 13, 475-480 (1976).
A. Katritzky et al., Synthesis, 10, 1487-1490 (1998).
F. Gatta et al., Edizione Scientifica, 30(8), 631-641 (1975), structures only.
W. Lopes et al., Journal of Brazilian Chemical Society, 4(1), 34-39 (1993).
S. Rosenzweig-Lipson et al., The FASEB Journal, 14, A1321 (2000).
McDevitt Robert E.
Ramamoorthy P. Sivaramakrishnan
Coleman Brenda
Hild Kimberly R.
Wyeth
LandOfFree
1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3565289